MyoKardia
Why Robinhood?
You can watch MyoKardia and buy or sell other stocks, ETFs, and their options commission-free!About MYOK
MyoKardia, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, commercialization, and development of therapies for the treatment of cardiovascular diseases. Its lead therapeutic candidate, Mavacamten, is an orally administered allosteric modulator of cardiac myosin being developed for the treatment of hypertrophic cardiomyopathy (HCM).
MYOK Key Statistics
Stock Snapshot
As of today, MyoKardia(MYOK) shares are valued at $224.91. The company's market cap stands at 11.99B, with a P/E ratio of -39.87.
On 2026-03-16, MyoKardia(MYOK) stock opened at —, reached a high of —, and a low of —.
The MyoKardia(MYOK)'s current trading volume is 0, compared to an average daily volume of 1.31M.
During the past year, MyoKardia(MYOK) stock moved between $42.65 at its lowest and $225.00 at its peak.
During the past year, MyoKardia(MYOK) stock moved between $42.65 at its lowest and $225.00 at its peak.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.